SUNPHARMA.NS Sun Pharmaceutical Industries Limited
Company Analysis
Latest News
Sun Pharma Settles US Price-Fixing Case, Resolving Major Legal Overhang
Sun Pharmaceutical Industries subsidiaries reached a settlement agreement in the In re Generic Pharmaceuticals Pricing Antitrust Litigation. The deal resolves...
Sun Pharma Cuts U.S. Drug Prices, Securing Two-Year Tariff Delay
Sun Pharmaceutical Industries signed a pricing agreement with the U.S. government during a White House ceremony. The company will provide Most Favored Nation...
Sun Pharma wins U.S. Lipitor antitrust appeal, ending decade-long legal battle
Sun Pharmaceutical Industries announced that the U.S. Court of Appeals for the Third Circuit affirmed a summary judgment in its favor. This ruling resolves an...
Sun Pharma fuels 12.1% India market jump, ending two-year slump
The Indian pharmaceutical market grew 12.1% year-on-year in July 2026. Sun Pharma emerged as a leading contributor to this expansion. The sector rebound...
Sun Pharma requires court approval for semaglutide launch, patent lawsuit
The Delhi High Court ordered Sun Pharmaceutical Industries to obtain judicial permission before launching its generic version of semaglutide. This directive...
Sun Pharma Profit Jumps 27%, Shares Slide on Weak US Sales
Sun Pharmaceutical Industries Ltd reported a 27% year-on-year increase in consolidated net profit for the quarter ending June 30, 2026. Net profit reached...
Sun Pharma Hits All-Time High, Driven by Heavy Institutional Buying
Sun Pharmaceutical Industries Ltd. shares reached a record high of ₹1,966.30 on July 27, 2026. The stock climbed 1.30% during the session, outperforming the...
Sun Pharma slides, as Trump plans 200% tariffs on generic drugs
Indian pharmaceutical stocks, including Sun Pharmaceutical Industries, declined on July 22, 2026. This follows US President Donald Trump’s announcement of a...
Sun Pharma hits record ₹1,963 high, defying broader market decline
Sun Pharmaceutical Industries Ltd. reached a new all-time high of ₹1,963 on July 21, 2026. The stock gained 0.36% during the session. This milestone occurred...